2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
5
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Colorectal Neoplasms
5
Small Cell Lung Carcinoma
4
Rectal Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Fibrosis
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Sprains and Strains
1
Smoldering Multiple Myeloma
1
Sepsis
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Interventions
Cyclophosphamide
16
Etoposide
14
Carboplatin
11
Temozolomide
10
Vincristine
9
Granulocyte Colony-Stimulating Factor
9
Filgrastim
9
Magnetic Resonance Spectroscopy
8
Cisplatin
8
etoposide phosphate
7
X-Rays
7
Thiotepa
7
Phantoms, Imaging
7
Methotrexate
7
tazemetostat
6
Topotecan
6
Specimen Handling
6
Radiotherapy
6
Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
fludarabine
4
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Melphalan
4
Biopsy
4
palbociclib
3
Sirolimus
3
Nivolumab
3
Leucovorin
3
Irinotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled